Login to Your Account

Policy disputes photo bomb first hearing on 'UFA' renewals

By Mari Serebrov
Regulatory Editor

Friday, March 3, 2017

A few lawmakers seized the first congressional hearing on the second rendition of the U.S. generic drug and biosimilar user fee agreements to frame their concerns about the administration's federal hiring freeze, regulatory crackdown and plans to replace the Affordable Care Act (ACA).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription